Loading…
A Three-Gene Signature for Outcome in Soft Tissue Sarcoma
Purpose: Finding markers or gene sets that would further classify patients into different risk categories and thus allow more individually adapted multimodality treatment regimens in soft tissue sarcomas is necessary. In this study, we investigated the prognostic values of hypoxia-inducible factor 1...
Saved in:
Published in: | Clinical cancer research 2009-08, Vol.15 (16), p.5191-5198 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Purpose: Finding markers or gene sets that would further classify patients into different risk categories and thus allow more individually
adapted multimodality treatment regimens in soft tissue sarcomas is necessary. In this study, we investigated the prognostic
values of hypoxia-inducible factor 1a ( HIF1a ), heparin-binding epidermal growth factorâlike growth factor ( HB-EGF ), vascular endothelial growth factor ( VEGF ), and other angiogenesis-related gene expressions, as well as their interrelationships.
Experimental Design: Formalin-fixed paraffin-embedded tissue samples were obtained from 45 patients with soft tissue sarcoma (median age 57 years,
range 16â85 years). After laser capture microdissection direct quantitative real-time reverse transcription-PCR (TaqMan) assays
were done in triplicates to determine HIF1a, HB-EGF, VEGF , and other gene expression levels.
Results: Multivariate Cox regression analysis revealed significant independent associations of HB-EGF, HIF1a , and VEGF-C gene expression to the overall survival ( P < 0.0001). A combined factor of these three genes showed a relative risk for shorter survival of 5.5, more than twice higher
as in an increasing International Union against Cancer Stage. Receiver operating characteristic curve analysis showed a significant
sensitivity of 73% and specificity of 82% of this factor for the diagnosis of short ( |
---|---|
ISSN: | 1078-0432 1557-3265 |
DOI: | 10.1158/1078-0432.CCR-08-2534 |